BioPharm Asia, Inc (fka BFAR)

[loupai]

Nam - the question of timing is that which I raised over at HSYT, which is ---can a foreign operational company ( and here i presume bfar will be able to find a retail arm) with little or no fraud ( here i presume another big leap) simply forget about its US equity holders and just truck along, filing SECs notices at their whim? what recourse would we have?

I suppose, the only hard fact we have is the auditors still state they represent bfar...at some point, if bfar isnt paying the bills, or not being responsive, i guess, one day, one of us will ask the auditor and they will reply that they no longer represent bfar.